The effects of intermittent androgen deprivation therapy (ADT) and zoledronic acid administration on bone density in patients with prostate cancer

被引：0
|
作者：
Katznelson, L. [1 ]
Kent, K. [1 ]
Srinivas, S. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15593
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Effects of Androgen Deprivation Therapy on Bone Microarchitecture and Hip Geometry in Patients with Prostate Cancer
    Hong, A. Ram
    Park, Ji Yong
    Choi, Wonsuk
    Yoon, Jee Hee
    Kim, Hee Kyung
    Kang, Ho-Cheol
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 164 - 165
  • [42] NO EFFECT OF PROTEIN SUPPLEMENTATION ON BONE MINERAL DENSITY IN PROSTATE CANCER PATIENTS ON ANDROGEN DEPRIVATION THERAPY
    Groenendijk, I.
    Houben, L. H. P.
    Overkamp, M.
    van Loon, L. J. C.
    Beelen, M.
    Beijer, S.
    De Groot, L.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S376 - S376
  • [43] Effect of different schemes of androgen deprivation therapy on bone mass density in prostate cancer patients
    Ruales, Karla Arevalo
    Cortes, Jose Ivorra
    Garcia, Elena Grau
    Donoso, Cesar David Vera
    Martinez, Antonio Jose Canada
    Ivorra, Jose Andres Roman
    MEDICINA CLINICA, 2023, 160 (02): : 51 - 59
  • [44] Evaluation of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for prostate cancer in Chinese population
    Yee, C. H.
    Ng, C. F.
    Wong, Y. F. A.
    Chan, C. K.
    Hou, S. M.
    Yip, K. H.
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A202 - A203
  • [45] Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer
    Miyazawa, Yoshiyuki
    Sekine, Yoshitaka
    Syuto, Takahiro
    Nomura, Masashi
    Koike, Hidekazu
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Ito, Kazuto
    Suzuki, Kazuhiro
    IN VIVO, 2018, 32 (02): : 409 - 412
  • [46] Bone mineral density in Japanese prostate cancer patients under androgen-deprivation therapy
    Wang, Wei
    Yuasa, Takeshi
    Tsuchiya, Norihiko
    Maita, Shinya
    Kumazawa, Teruaki
    Inoue, Takamitsu
    Saito, Mitsuru
    Ma, Zhiyong
    Obara, Takashi
    Tsuruta, Hiroshi
    Satoh, Shigeru
    Habuchi, Tomonori
    ENDOCRINE-RELATED CANCER, 2008, 15 (04) : 943 - 952
  • [47] UK HOSPITALIZATIONS DUE TO STROKE IN PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN DEPRIVATION THERAPY (ADT)
    Jefferies, Edward
    Bahl, Amit
    Hounsome, Luke
    Eylert, Maike
    Verne, Julia
    Persad, Raj
    JOURNAL OF UROLOGY, 2012, 187 (04): : E381 - E382
  • [48] Androgen deprivation therapy (ADT) and testosterone (T) in prostate cancer patients: The lower is really the better
    Perachino, M.
    Cavalli, V.
    Ferraris, V.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 204 - 204
  • [49] Health-related quality of life of prostate cancer patients on androgen deprivation therapy (ADT)
    Ko, C. H.
    Lim, J.
    Ng, C. F.
    Wei, Y.
    Ong, T. A.
    Chu, P. S. K.
    Chan, W.
    Huang, C. Y.
    Feng, K. K.
    Teoh, J.
    Ning, X.
    Chiu, P.
    Yee, C. H.
    Leung, S.
    BJU INTERNATIONAL, 2022, 129 : 6 - 6
  • [50] Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
    Wolff, Johannes M.
    Abrahamsson, Per-Anders
    Irani, Jacques
    da Silva, Fernando Calais
    BJU INTERNATIONAL, 2014, 114 (04) : 476 - 483
12345